D. E. Shaw & Co., Inc. Arrowhead Pharmaceuticals, Inc. Put Options Transaction History

D. E. Shaw & Co., Inc.

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$19.36 - $29.54 $214,896 - $327,894	11,100 New	11,100 $214,000
Q1 2022 May 16, 2022	SELL	$39.62 - $69.97 $396,200 - $699,700	-10,000 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$33.21 - $51.27 $826,929 - $1.28 Million	-24,900 Reduced 71.35%	10,000 $431,000
Q2 2020 Aug 14, 2020	BUY	$26.12 - $43.27 $389,188 - $644,723	14,900 Added 74.5%	34,900 $1.51 Million
Q4 2019 Feb 14, 2020	BUY	$28.14 - $73.01 $562,800 - $1.46 Million	20,000 New	20,000 $1.27 Million

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.